Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Iron sorbitol adverse reaction (disorder) |
Causative agent (attribute) |
True |
Iron sorbitol (substance) |
Inferred relationship |
Some |
1 |
Allergy to iron sorbitol |
Causative agent (attribute) |
False |
Iron sorbitol (substance) |
Inferred relationship |
Some |
|
Product containing iron sorbitol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iron sorbitol (substance) |
Inferred relationship |
Some |
1 |
Iron sorbitol (50mg/mL Ferrous iron) injection solution 2mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Iron sorbitol (substance) |
Inferred relationship |
Some |
|
Allergy to iron sorbitol |
Causative agent (attribute) |
True |
Iron sorbitol (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely iron (as iron sorbitol) 100 milligram/2 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Iron sorbitol (substance) |
Inferred relationship |
Some |
1 |
Iron sorbitol-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iron sorbitol (substance) |
Inferred relationship |
Some |
1 |
Iron sorbitol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iron sorbitol (substance) |
Inferred relationship |
Some |
1 |
Product containing only iron sorbitol in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Iron sorbitol (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely iron (as iron sorbitol) 50 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Iron sorbitol (substance) |
Inferred relationship |
Some |
1 |